Shrujna Patel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Shrujna Patel has a total of 115 co-authors. Here are the top co-authors by number of shared publications:
- Russell Clive Dale
Kids Neuroscience Centre, The Children's Hospital at Westmead, Faculty of Medicine and Health, University of Sydney, NSW, Australia; The Children's Hospital at Westmead Clinical School, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia; The University of Sydney, School of Medical Sciences and Discipline of Child and Adolescent Health, Faculty of Medicine and Health, Sydney, NSW, Australia
13 shared publications - Shekeeb S. Mohammad
The Children's Hospital at Westmead
10 shared publications - Velda Xinying Han
Khoo Teck Puat‐National University Children's Medical Institute National University Health System Singapore
10 shared publications - Ruwani Dissanayake
Australian Genome Research Facility Ltd, Westmead, NSW, Australia
7 shared publications - Brooke A. Keating
Kids Neuroscience Centre, The Children's Hospital at Westmead, Faculty of Medicine and Health, University of Sydney, NSW, Australia
6 shared publications - Xianzhong Lau
Australian Genome Research Facility Ltd, Melbourne, VIC, Australia
6 shared publications
Latest Publications
- Open Access
- 16 September 2026
- Published by Elsevier in SSRN Electronic Journal
Ketogenic Diet Modifies Chromatin and Gene-Regulatory Pathways in Paediatric Epilepsy
Background: The ketogenic diet (KD) is an established treatment for refractory epilepsy, however its mechanisms of action remain unclear.Methods: Bulk RNA sequencing, mass spectrometry proteomics and phosphoproteomics of peripheral blood were used to explore molecular effects of the KD in 14 children with epilepsy (median age 3.0 years [range 0.1-5.7], 71.4% male) at baseline and 3 months on KD, compared to 14 age- and sex-matched controls. Clinical outcomes included seizure frequency and Clinical Global Impression–Improvement (CGI-I). Differential gene expression, protein and phosphosite abundance, and gene set enrichment analyses identified epilepsy-associated molecular pathways that were dysregulated at baseline and then reversed on KD (FDR <0.05).Findings: Median seizure frequency decreased from 6.5 to 0.7 per day (median reduction 59.5%). Eight of 14 children achieved ≥50% seizure reduction, four achieved ≥90%, and three were seizure-free at 3 months. CGI-I indicated improvement in 8/14 children. At baseline, the multi-omic datasets indicated dysregulated chromatin and transcription-related pathways in the epilepsy patients compared to controls, which were reversed after 3 months on KD. Other dysregulated pathways that were reversed by KD involved antigen presentation, mitochondrial function, oxidative stress, proteostasis, membrane transport, and synaptic signalling. Interpretation: KD was associated with clinically meaningful seizure reduction in children with epilepsy after 3 months on diet. Multi-omic convergence of chromatin and transcriptional signals supports gene regulation as a component of KD action, potentially interacting with metabolic, mitochondrial, membrane, immune, and signalling processes. Our data supports the established action of ketone bodies on histone modification and chromatin structure.
- 16 September 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessKetogenic Diet Modifies Chromatin and Gene-Regulatory Pathways in Paediatric Epilepsy
Background: The ketogenic diet (KD) is an established treatment for refractory epilepsy, however its mechanisms of action remain unclear.Methods: Bulk RNA sequencing, mass spectrometry proteomics and phosphoproteomics of peripheral blood were used to explore molecular effects of the KD in 14 children with epilepsy (median age 3.0 years [range 0.1-5.7], 71.4% male) at baseline and 3 months on KD, compared to 14 age- and sex-matched controls. Clinical outcomes included seizure frequency and Clinical Global Impression–Improvement (CGI-I). Differential gene expression, protein and phosphosite abundance, and gene set enrichment analyses identified epilepsy-associated molecular pathways that were dysregulated at baseline and then reversed on KD (FDR <0.05).Findings: Median seizure frequency decreased from 6.5 to 0.7 per day (median reduction 59.5%). Eight of 14 children achieved ≥50% seizure reduction, four achieved ≥90%, and three were seizure-free at 3 months. CGI-I indicated improvement in 8/14 children. At baseline, the multi-omic datasets indicated dysregulated chromatin and transcription-related pathways in the epilepsy patients compared to controls, which were reversed after 3 months on KD. Other dysregulated pathways that were reversed by KD involved antigen presentation, mitochondrial function, oxidative stress, proteostasis, membrane transport, and synaptic signalling. Interpretation: KD was associated with clinically meaningful seizure reduction in children with epilepsy after 3 months on diet. Multi-omic convergence of chromatin and transcriptional signals supports gene regulation as a component of KD action, potentially interacting with metabolic, mitochondrial, membrane, immune, and signalling processes. Our data supports the established action of ketone bodies on histone modification and chromatin structure.
- Open Access
- 21 May 2026
- Published by Springer Nature in Research Square
Neurodevelopmental regression is associated with chromatin, transcriptional and immune dysregulation which can be reversed by HDAC inhibition
Neurodevelopmental regression in children, including autistic regression, is often associated with inconclusive diagnostic investigations, leaving the underlying pathophysiology poorly understood. We conducted peripheral blood multi-omic profiling in 15 children with neurodevelopmental regression (median age 9 (4-14) years, 60% males, 7 had developmental issues prior to regression), and 18 healthy controls (median age 12 (7-16) years, 56% males). Our comprehensive analysis included peripheral blood bulk RNA sequencing (8 regression vs. 8 controls), single-cell RNA sequencing (two cohorts of 4 regression vs. 4 controls), bulk proteomics (4 regression vs. 4 controls), phosphoproteomics (4 regression vs. 4 controls), and analysis of transposase-accessible chromatin (ATAC) sequencing (8 regression vs. 6 controls). Despite clinical heterogeneity, we identified convergent pathophysiological processes, including dysregulated epigenetic pathways (chromatin remodelling, histone modifications, transcription factors) and immune responses, as well as downregulated ribosomal and translational pathways. Our data supports a predisposition to a heterochromatin (closed) state in patients. We therefore treated patient PBMCs with in vitro histone deacetylase inhibitor, givinostat, to modulate RNA expression (1 regression vs. 1 control). Through single-cell RNA sequencing, we showed that in vitro givinostat reversed the dysregulated ribosomal and translational pathways, and downregulated immune pathways in patient PBMCs. Disruptions in epigenetic, immune and translational processes may arise from complex genetic and environmental interactions in children with neurodevelopmental regression. Therapies that target immune dysregulation or epigenetic modifications may represent effective treatment options for these individuals.
- 21 May 2026
- Published by Springer Nature in Research Square
Open AccessNeurodevelopmental regression is associated with chromatin, transcriptional and immune dysregulation which can be reversed by HDAC inhibition
Neurodevelopmental regression in children, including autistic regression, is often associated with inconclusive diagnostic investigations, leaving the underlying pathophysiology poorly understood. We conducted peripheral blood multi-omic profiling in 15 children with neurodevelopmental regression (median age 9 (4-14) years, 60% males, 7 had developmental issues prior to regression), and 18 healthy controls (median age 12 (7-16) years, 56% males). Our comprehensive analysis included peripheral blood bulk RNA sequencing (8 regression vs. 8 controls), single-cell RNA sequencing (two cohorts of 4 regression vs. 4 controls), bulk proteomics (4 regression vs. 4 controls), phosphoproteomics (4 regression vs. 4 controls), and analysis of transposase-accessible chromatin (ATAC) sequencing (8 regression vs. 6 controls). Despite clinical heterogeneity, we identified convergent pathophysiological processes, including dysregulated epigenetic pathways (chromatin remodelling, histone modifications, transcription factors) and immune responses, as well as downregulated ribosomal and translational pathways. Our data supports a predisposition to a heterochromatin (closed) state in patients. We therefore treated patient PBMCs with in vitro histone deacetylase inhibitor, givinostat, to modulate RNA expression (1 regression vs. 1 control). Through single-cell RNA sequencing, we showed that in vitro givinostat reversed the dysregulated ribosomal and translational pathways, and downregulated immune pathways in patient PBMCs. Disruptions in epigenetic, immune and translational processes may arise from complex genetic and environmental interactions in children with neurodevelopmental regression. Therapies that target immune dysregulation or epigenetic modifications may represent effective treatment options for these individuals.
- Open Access
- 1 November 2025
- Published by Wolters Kluwer Health in Neurology Neuroimmunology & Neuroinflammation
- Vol. 12 (6) , e200467
IV Immunoglobulin Is Associated With Epigenetic, Ribosomal, and Immune Changes in Pediatric Acute-Onset Neuropsychiatric Syndrome
Pediatric acute-onset neuropsychiatric syndrome (PANS) is characterized by infection-provoked abrupt-onset obsessive compulsive disorder (OCD) and neurodevelopmental regression. Owing to the neuroimmune hypothesis, we investigated the effects of IV immunoglobulin (IVIg) on cell-specific gene expression. Single-cell RNA sequencing of peripheral immune cells was performed in 5 children with PANS (median age 8 (5.5-16) years), before and after administering open-label IVIg, compared with 4 controls (median age 13.5 [IQR 12-15] years). The index PANS event (age 1.8-13 years) involved abrupt eating restriction (n = 5), developmental regression (n = 4), and OCD (n = 3). A total of 144,470 cells were sequenced and clustered into 11 cell types. Children with PANS before IVIg compared with controls showed downregulated immune pathways (defense response, innate immunity, secretory granules) in most cell types, with natural killer (NK) cells showing upregulated immune pathways (response to corticosteroid), supporting baseline "immune dysregulation." Ribosomal pathways were upregulated in neutrophils and CD8 T cells but downregulated in NK cells. In children with PANS after IVIg, the baseline immune and ribosomal pathway abnormalities were reversed and histone modification pathways (histone methyltransferase, chromatin) were downregulated in neutrophils and NK cells. We propose that PANS is an epigenetic immune brain disorder with cellular epigenetic, ribosomal, and immune dysregulation. Epigenetic and immune-modulating therapies, such as IVIg, may have disease-modifying effects.
- 1 November 2025
- Published by Wolters Kluwer Health in Neurology Neuroimmunology & Neuroinflammation
- Vol. 12 (6) , e200467
Open AccessIV Immunoglobulin Is Associated With Epigenetic, Ribosomal, and Immune Changes in Pediatric Acute-Onset Neuropsychiatric Syndrome
Pediatric acute-onset neuropsychiatric syndrome (PANS) is characterized by infection-provoked abrupt-onset obsessive compulsive disorder (OCD) and neurodevelopmental regression. Owing to the neuroimmune hypothesis, we investigated the effects of IV immunoglobulin (IVIg) on cell-specific gene expression. Single-cell RNA sequencing of peripheral immune cells was performed in 5 children with PANS (median age 8 (5.5-16) years), before and after administering open-label IVIg, compared with 4 controls (median age 13.5 [IQR 12-15] years). The index PANS event (age 1.8-13 years) involved abrupt eating restriction (n = 5), developmental regression (n = 4), and OCD (n = 3). A total of 144,470 cells were sequenced and clustered into 11 cell types. Children with PANS before IVIg compared with controls showed downregulated immune pathways (defense response, innate immunity, secretory granules) in most cell types, with natural killer (NK) cells showing upregulated immune pathways (response to corticosteroid), supporting baseline "immune dysregulation." Ribosomal pathways were upregulated in neutrophils and CD8 T cells but downregulated in NK cells. In children with PANS after IVIg, the baseline immune and ribosomal pathway abnormalities were reversed and histone modification pathways (histone methyltransferase, chromatin) were downregulated in neutrophils and NK cells. We propose that PANS is an epigenetic immune brain disorder with cellular epigenetic, ribosomal, and immune dysregulation. Epigenetic and immune-modulating therapies, such as IVIg, may have disease-modifying effects.
- Open Access
- 30 August 2025
- Published by Springer Nature in Molecular Psychiatry
- Vol. 30 (11) , 5389-5404
Epigenetic, ribosomal, and immune dysregulation in paediatric acute-onset neuropsychiatric syndrome
Paediatric Acute-Onset Neuropsychiatric Syndrome (PANS) is characterised by abrupt onset obsessive compulsive disorder and regression in neurodevelopmental skills, triggered by infection or stress. Whether PANS is a distinct entity or part of a neurodevelopmental spectrum is uncertain, and its pathophysiology remains unclear. We show that children with PANS (n = 32) and other non-PANS (n = 68) neurodevelopmental disorders (total n = 100) have higher reported early childhood infections and a loss of previously acquired developmental skills compared to neurotypical controls (n = 58). Children with PANS have normal routine immune testing, however bulk RNA-sequencing (PANS n = 20 vs controls n = 15) revealed upregulated pathways in ribosomal biogenesis and RNA methyltransferases, and downregulated pathways in diverse cellular functions such as mitochondrial activity, cell signalling, endocytosis, and immune responses. Single-cell RNA-sequencing (PANS n = 2 vs controls n = 2) confirmed these findings but showed heterogeneity across immune cell types. Toll-like receptor stimulation assay using peripheral blood mononuclear cells revealed reduced TNF and interleukin-6 responses in PANS patients (n = 7) compared to controls (n = 7). RNA sequencing before and after intravenous immunoglobulin treatment in PANS patients (n = 9 vs controls n = 10) revealed reversal of the dysregulated ribosomal, epigenetic, and cell signaling pathways. Given the central role of the immune system in synaptic pruning and neurodevelopment, these insights provide rationale for novel epigenetic and immune modulating therapies to optimize neurodevelopmental trajectories and minimize neuropsychiatric impairment in PANS.
- 30 August 2025
- Published by Springer Nature in Molecular Psychiatry
- Vol. 30 (11) , 5389-5404
Open AccessEpigenetic, ribosomal, and immune dysregulation in paediatric acute-onset neuropsychiatric syndrome
Paediatric Acute-Onset Neuropsychiatric Syndrome (PANS) is characterised by abrupt onset obsessive compulsive disorder and regression in neurodevelopmental skills, triggered by infection or stress. Whether PANS is a distinct entity or part of a neurodevelopmental spectrum is uncertain, and its pathophysiology remains unclear. We show that children with PANS (n = 32) and other non-PANS (n = 68) neurodevelopmental disorders (total n = 100) have higher reported early childhood infections and a loss of previously acquired developmental skills compared to neurotypical controls (n = 58). Children with PANS have normal routine immune testing, however bulk RNA-sequencing (PANS n = 20 vs controls n = 15) revealed upregulated pathways in ribosomal biogenesis and RNA methyltransferases, and downregulated pathways in diverse cellular functions such as mitochondrial activity, cell signalling, endocytosis, and immune responses. Single-cell RNA-sequencing (PANS n = 2 vs controls n = 2) confirmed these findings but showed heterogeneity across immune cell types. Toll-like receptor stimulation assay using peripheral blood mononuclear cells revealed reduced TNF and interleukin-6 responses in PANS patients (n = 7) compared to controls (n = 7). RNA sequencing before and after intravenous immunoglobulin treatment in PANS patients (n = 9 vs controls n = 10) revealed reversal of the dysregulated ribosomal, epigenetic, and cell signaling pathways. Given the central role of the immune system in synaptic pruning and neurodevelopment, these insights provide rationale for novel epigenetic and immune modulating therapies to optimize neurodevelopmental trajectories and minimize neuropsychiatric impairment in PANS.
- Open Access
Epigenetic, ribosomal, and immune dysregulation in Paediatric Acute-Onset Neuropsychiatric Syndrome
Paediatric Acute-Onset Neuropsychiatric Syndrome (PANS) is characterised by abrupt onset obsessive compulsive disorder and regression in neurodevelopmental skills, triggered by infection or stress. Whether PANS is a distinct entity or part of a neurodevelopmental spectrum is uncertain, and its pathophysiology remains unclear. We show that children with PANS (n=32) and other non-PANS (n=68) neurodevelopmental disorders (total n=100) have higher reported early childhood infections and a loss of previously acquired developmental skills compared to neurotypical controls (n=58). Children with PANS have normal routine immune testing, however bulk RNA-sequencing (PANS n=20 vs controls n=15) revealed upregulated pathways in ribosomal biogenesis and RNA methyltransferases, and downregulated pathways in diverse cellular functions such as mitochondrial activity, cell signalling, endocytosis, and immune responses. Single-cell RNA-sequencing (PANS n=2 vs controls n=2) confirmed these findings but showed heterogeneity across immune cell types. Toll-like receptor stimulation assay using peripheral blood mononuclear cells revealed reduced TNF and interleukin-6 responses in PANS patients (n=7) compared to controls (n=7). RNA sequencing before and after intravenous immunoglobulin treatment in PANS patients (n=9 vs controls n=10) revealed reversal of the dysregulated ribosomal, epigenetic, and cell signaling pathways. Given the central role of the immune system in synaptic pruning and neurodevelopment, these insights provide rationale for novel epigenetic and immune modulating therapies to optimize neurodevelopmental trajectories and minimize neuropsychiatric impairment.
Open AccessEpigenetic, ribosomal, and immune dysregulation in Paediatric Acute-Onset Neuropsychiatric Syndrome
Paediatric Acute-Onset Neuropsychiatric Syndrome (PANS) is characterised by abrupt onset obsessive compulsive disorder and regression in neurodevelopmental skills, triggered by infection or stress. Whether PANS is a distinct entity or part of a neurodevelopmental spectrum is uncertain, and its pathophysiology remains unclear. We show that children with PANS (n=32) and other non-PANS (n=68) neurodevelopmental disorders (total n=100) have higher reported early childhood infections and a loss of previously acquired developmental skills compared to neurotypical controls (n=58). Children with PANS have normal routine immune testing, however bulk RNA-sequencing (PANS n=20 vs controls n=15) revealed upregulated pathways in ribosomal biogenesis and RNA methyltransferases, and downregulated pathways in diverse cellular functions such as mitochondrial activity, cell signalling, endocytosis, and immune responses. Single-cell RNA-sequencing (PANS n=2 vs controls n=2) confirmed these findings but showed heterogeneity across immune cell types. Toll-like receptor stimulation assay using peripheral blood mononuclear cells revealed reduced TNF and interleukin-6 responses in PANS patients (n=7) compared to controls (n=7). RNA sequencing before and after intravenous immunoglobulin treatment in PANS patients (n=9 vs controls n=10) revealed reversal of the dysregulated ribosomal, epigenetic, and cell signaling pathways. Given the central role of the immune system in synaptic pruning and neurodevelopment, these insights provide rationale for novel epigenetic and immune modulating therapies to optimize neurodevelopmental trajectories and minimize neuropsychiatric impairment.
- Open Access
Intravenous immunoglobulin has epigenetic, ribosomal, and immune effects in Paediatric Acute-Onset Neuropsychiatric Syndrome
Paediatric acute-onset neuropsychiatric syndrome (PANS) is characterised by infection-provoked abrupt and dramatic onset of obsessive compulsive disorder (OCD) or eating restriction, along with neurodevelopmental regression. Although the aetiology of PANS remains uncertain, due to a prevailing neuroimmune hypothesis some children receive the immune modulator intravenous immunoglobulin (IVIg). Using single-cell RNA sequencing of peripheral immune cells, we examined gene expression in five children with PANS (mean age 10.2 years, range 5–17, 60% male) who were receiving open-label IVIg. Maternal autoimmunity (n=3) and familial neurodevelopmental/neuropsychiatric disorders (n=5) were present. The index PANS event occurred age 1.8–13 years, characterised by abrupt eating restriction (n=5), developmental regression (n=4), and OCD (n=3). Single-cell RNA sequencing (144,470 cells) was performed in five patients pre- and post-IVIg, and four controls (mean age 13.5 years, range 11–16, 50% male). In PANS pre-IVIg compared to neurotypical controls, there were downregulated immune pathways (defense response, innate immunity, secretory granules) in most cell types. However, NK cells exhibited upregulated immune pathways (response to corticosteroid), supporting a baseline ‘immune dysregulation’. In PANS pre-IVIg compared to controls, ribosomal pathways were upregulated in neutrophils and CD8 T cells, but downregulated in NK cells. Post-IVIg, the previously downregulated immune pathways were upregulated in most cell types, and the baseline ribosomal pathway abnormalities were reversed. Additionally, histone modification pathways (histone methyltransferase, chromatin) were downregulated in neutrophils and NK cells post-IVIg. We propose PANS is an epigenetic immune-brain disorder with cellular epigenetic, ribosomal, and immune dysregulation. Therefore, epigenetic and immune-modulating therapies, such as IVIg, may have a critical role in treating this disabling disorder. Highlights: Five children with PANS receiving monthly IVIg who had clinical benefit were studied Three young boys had a regressive (autistic) phenotype, whereas the older two girls had OCD Single-cell RNA sequencing showed epigenetic, ribosomal, and immune dysregulation in PANS IVIg treatment had epigenetic and immune-modulating effects in PANS IVIg altered gene expression of histone methyltransferase and chromatin genes
Open AccessIntravenous immunoglobulin has epigenetic, ribosomal, and immune effects in Paediatric Acute-Onset Neuropsychiatric Syndrome
Paediatric acute-onset neuropsychiatric syndrome (PANS) is characterised by infection-provoked abrupt and dramatic onset of obsessive compulsive disorder (OCD) or eating restriction, along with neurodevelopmental regression. Although the aetiology of PANS remains uncertain, due to a prevailing neuroimmune hypothesis some children receive the immune modulator intravenous immunoglobulin (IVIg). Using single-cell RNA sequencing of peripheral immune cells, we examined gene expression in five children with PANS (mean age 10.2 years, range 5–17, 60% male) who were receiving open-label IVIg. Maternal autoimmunity (n=3) and familial neurodevelopmental/neuropsychiatric disorders (n=5) were present. The index PANS event occurred age 1.8–13 years, characterised by abrupt eating restriction (n=5), developmental regression (n=4), and OCD (n=3). Single-cell RNA sequencing (144,470 cells) was performed in five patients pre- and post-IVIg, and four controls (mean age 13.5 years, range 11–16, 50% male). In PANS pre-IVIg compared to neurotypical controls, there were downregulated immune pathways (defense response, innate immunity, secretory granules) in most cell types. However, NK cells exhibited upregulated immune pathways (response to corticosteroid), supporting a baseline ‘immune dysregulation’. In PANS pre-IVIg compared to controls, ribosomal pathways were upregulated in neutrophils and CD8 T cells, but downregulated in NK cells. Post-IVIg, the previously downregulated immune pathways were upregulated in most cell types, and the baseline ribosomal pathway abnormalities were reversed. Additionally, histone modification pathways (histone methyltransferase, chromatin) were downregulated in neutrophils and NK cells post-IVIg. We propose PANS is an epigenetic immune-brain disorder with cellular epigenetic, ribosomal, and immune dysregulation. Therefore, epigenetic and immune-modulating therapies, such as IVIg, may have a critical role in treating this disabling disorder. Highlights: Five children with PANS receiving monthly IVIg who had clinical benefit were studied Three young boys had a regressive (autistic) phenotype, whereas the older two girls had OCD Single-cell RNA sequencing showed epigenetic, ribosomal, and immune dysregulation in PANS IVIg treatment had epigenetic and immune-modulating effects in PANS IVIg altered gene expression of histone methyltransferase and chromatin genes
- Open Access
Cumulative pregnancy and postnatal environmental exposures impact social behaviour in male mice associated with epigenetic, ribosomal, and immune dysregulation
Environmental exposures across critical developmental windows can significantly influence brain development and contribute to the pathogenesis of neurodevelopmental disorders (NDDs). Emerging clinical evidence suggests that cumulative environmental factors during early development result in more pronounced disease phenotypes in offspring. Here, we developed a ‘triple-hit’ model using C57Bl/6JAusb mice to examine the cumulative effects of antenatal social stress, antenatal chronic high-fat diet consumption, and postnatal poly(I:C) exposure on neurodevelopmental outcomes in offspring. Male ‘triple-hit’ offspring displayed autism-like social deficits and an overall increased susceptibility to neurodevelopmental behavioural alterations in adulthood compared to male non-stressed controls. Conversely, these behavioural changes were not observed amongst female ‘triple-hit’ offspring. Single-cell RNA (scRNA) transcriptomic and bulk proteomic sequencing were performed in male ‘triple-hit’ offspring across peripheral blood immune cells and brain tissue. scRNA sequencing in microglia, astrocytes, and oligodendrocytes revealed dysregulation in critical glial cell processes, ribosomal functions, and chromatin remodelling. Similar functional themes were observed across peripheral blood macrophages, neutrophils, and naïve B cells - displaying immune and ribosomal dysregulation at the transcriptional level. Proteomics pathway enrichment analyses revealed significantly reduced protein abundance in ribosomal biogenesis, translation, and chromatin remodelling functions in both peripheral blood immune cells and brain tissue. We also observed synaptic dysfunction in the blood and brain proteome. Overall, using our unique ‘triple-hit’ model, we demonstrate that multiple early life environmental exposures drive NDD-associated behaviours in a sex-specific manner; and is associated with overlapping central and peripheral molecular mechanisms that have clinical relevance to NDD pathogenesis.
Open AccessCumulative pregnancy and postnatal environmental exposures impact social behaviour in male mice associated with epigenetic, ribosomal, and immune dysregulation
Environmental exposures across critical developmental windows can significantly influence brain development and contribute to the pathogenesis of neurodevelopmental disorders (NDDs). Emerging clinical evidence suggests that cumulative environmental factors during early development result in more pronounced disease phenotypes in offspring. Here, we developed a ‘triple-hit’ model using C57Bl/6JAusb mice to examine the cumulative effects of antenatal social stress, antenatal chronic high-fat diet consumption, and postnatal poly(I:C) exposure on neurodevelopmental outcomes in offspring. Male ‘triple-hit’ offspring displayed autism-like social deficits and an overall increased susceptibility to neurodevelopmental behavioural alterations in adulthood compared to male non-stressed controls. Conversely, these behavioural changes were not observed amongst female ‘triple-hit’ offspring. Single-cell RNA (scRNA) transcriptomic and bulk proteomic sequencing were performed in male ‘triple-hit’ offspring across peripheral blood immune cells and brain tissue. scRNA sequencing in microglia, astrocytes, and oligodendrocytes revealed dysregulation in critical glial cell processes, ribosomal functions, and chromatin remodelling. Similar functional themes were observed across peripheral blood macrophages, neutrophils, and naïve B cells - displaying immune and ribosomal dysregulation at the transcriptional level. Proteomics pathway enrichment analyses revealed significantly reduced protein abundance in ribosomal biogenesis, translation, and chromatin remodelling functions in both peripheral blood immune cells and brain tissue. We also observed synaptic dysfunction in the blood and brain proteome. Overall, using our unique ‘triple-hit’ model, we demonstrate that multiple early life environmental exposures drive NDD-associated behaviours in a sex-specific manner; and is associated with overlapping central and peripheral molecular mechanisms that have clinical relevance to NDD pathogenesis.
- Open Access
Chromatin, transcriptional and immune dysregulation in children with neurodevelopmental regression
Summary: Neurodevelopmental including autistic regression in children is often associated with inconclusive diagnostic investigations, leaving the underlying pathophysiology largely unexplored and poorly understood. To address this, we conducted peripheral blood multi-omics profiling in 15 children with neurodevelopmental regression (median age 9 (4-14) years, 60% males), and 15 healthy controls (median age 12 (7-16) years, 60% males). Our comprehensive analysis included bulk RNA sequencing (8 regression vs. 8 controls), single-cell RNA sequencing (two cohorts of 4 regression vs. 4 controls), bulk proteomics (4 regression vs. 4 controls), and phosphoproteomics (4 regression vs. 4 controls). Despite clinical heterogeneity, we identified convergent pathophysiological processes, including dysregulated pathways in epigenetic pathways (chromatin remodelling, histone modifications, transcription factors) and immune responses, as well as downregulated ribosomal and translational pathways. These disruptions in epigenetic, immune and translational processes may arise from complex genetic and environmental interactions, offering opportunities for therapeutic interventions that specifically target these pathways.
Open AccessChromatin, transcriptional and immune dysregulation in children with neurodevelopmental regression
Summary: Neurodevelopmental including autistic regression in children is often associated with inconclusive diagnostic investigations, leaving the underlying pathophysiology largely unexplored and poorly understood. To address this, we conducted peripheral blood multi-omics profiling in 15 children with neurodevelopmental regression (median age 9 (4-14) years, 60% males), and 15 healthy controls (median age 12 (7-16) years, 60% males). Our comprehensive analysis included bulk RNA sequencing (8 regression vs. 8 controls), single-cell RNA sequencing (two cohorts of 4 regression vs. 4 controls), bulk proteomics (4 regression vs. 4 controls), and phosphoproteomics (4 regression vs. 4 controls). Despite clinical heterogeneity, we identified convergent pathophysiological processes, including dysregulated pathways in epigenetic pathways (chromatin remodelling, histone modifications, transcription factors) and immune responses, as well as downregulated ribosomal and translational pathways. These disruptions in epigenetic, immune and translational processes may arise from complex genetic and environmental interactions, offering opportunities for therapeutic interventions that specifically target these pathways.
- Open Access
- 28 February 2025
- Published by Wiley in Developmental Medicine & Child Neurology
- Vol. 67 (8) , 1004-1025
Aetiopathogenesis of infantile epileptic spasms syndrome and mechanisms of action of adrenocorticotrophin hormone/corticosteroids in children: A scoping review
Aim: To review the aetiopathogenesis of infantile epileptic spasms syndrome (IESS) and mechanisms of action of adrenocorticotrophin hormone (ACTH)/corticosteroids established in humans.Method: MEDLINE, PubMed, and Embase were systematically searched from inception to December 2023 to identify studies related to IESS aetiology and treatment response. Mechanistic themes were identified and through consensus meetings refined and grouped into five overarching hypotheses.Results: Five hypotheses were generated from 17 mechanistic themes: (1) gene and epigenetic regulation altering expression of ‘vulnerability’ genes; (2) stress and hypothalamic–pituitary–adrenal axis activation; (3) neuroinflammation and altered immune function; (4) altered neuronal transmission and pathways; and (5) dysfunction of metabolic pathways.Interpretation: The evidence that ACTH/corticosteroids alter these processes remains limited. It is plausible that these processes interact with one another, rather than existing independently, and affect maturational and regulatory processes in the central nervous system, consistent with proposals that IESS is a neurodevelopmental disorder. Understanding how ACTH/corticosteroids work in IESS may facilitate disease‐modifying treatments and improve neurodevelopmental outcomes.
- 28 February 2025
- Published by Wiley in Developmental Medicine & Child Neurology
- Vol. 67 (8) , 1004-1025
Open AccessAetiopathogenesis of infantile epileptic spasms syndrome and mechanisms of action of adrenocorticotrophin hormone/corticosteroids in children: A scoping review
Aim: To review the aetiopathogenesis of infantile epileptic spasms syndrome (IESS) and mechanisms of action of adrenocorticotrophin hormone (ACTH)/corticosteroids established in humans.Method: MEDLINE, PubMed, and Embase were systematically searched from inception to December 2023 to identify studies related to IESS aetiology and treatment response. Mechanistic themes were identified and through consensus meetings refined and grouped into five overarching hypotheses.Results: Five hypotheses were generated from 17 mechanistic themes: (1) gene and epigenetic regulation altering expression of ‘vulnerability’ genes; (2) stress and hypothalamic–pituitary–adrenal axis activation; (3) neuroinflammation and altered immune function; (4) altered neuronal transmission and pathways; and (5) dysfunction of metabolic pathways.Interpretation: The evidence that ACTH/corticosteroids alter these processes remains limited. It is plausible that these processes interact with one another, rather than existing independently, and affect maturational and regulatory processes in the central nervous system, consistent with proposals that IESS is a neurodevelopmental disorder. Understanding how ACTH/corticosteroids work in IESS may facilitate disease‐modifying treatments and improve neurodevelopmental outcomes.
- Open Access
- 22 February 2025
- Published by Wiley in Developmental Medicine & Child Neurology
- Vol. 67 (8) , 1095-1102
Pathogenic variants in chromatin‐related genes: Linking immune dysregulation to neuroregression and acute neuropsychiatric disorders
We report eight children with de novo pathogenic DNA variants in chromatin‐related genes: MORC2, CHD7, KANSL1, KMT2D, ZMYND11, HIST1HIE, EP300, and KMT2B. All children experienced infection or vaccine‐provoked neuroregression or abrupt‐onset neuropsychiatric syndromes. Most had delayed development (n = 6) before the first regression, and four had immune deficiency or autoimmunity (n = 4). At a mean age of 4 years 2 months (range 1–8 years), symptoms included infection‐provoked autistic/language regression (n = 6), cognitive decline (n = 3), gait deterioration (n = 3), or abrupt‐onset anxiety, obsessive‐compulsive disorder, and/or tics (n = 5). Three children had ongoing infection‐provoked deteriorations. Six children benefited from intravenous immunoglobulin (n = 3) or antibiotics (n = 4). Ribonucleic acid expression of the eight chromatin genes was similar in neuronal, glial, and peripheral leukocytes, unlike non‐chromatin neurodevelopmental genes, which have predominantly neuronal expression. These cases demonstrate the role of chromatin dysregulation in autistic regression and abrupt‐onset neuropsychiatric syndromes, potentially related to brain and immune gene dysregulation.
- 22 February 2025
- Published by Wiley in Developmental Medicine & Child Neurology
- Vol. 67 (8) , 1095-1102
Open AccessPathogenic variants in chromatin‐related genes: Linking immune dysregulation to neuroregression and acute neuropsychiatric disorders
We report eight children with de novo pathogenic DNA variants in chromatin‐related genes: MORC2, CHD7, KANSL1, KMT2D, ZMYND11, HIST1HIE, EP300, and KMT2B. All children experienced infection or vaccine‐provoked neuroregression or abrupt‐onset neuropsychiatric syndromes. Most had delayed development (n = 6) before the first regression, and four had immune deficiency or autoimmunity (n = 4). At a mean age of 4 years 2 months (range 1–8 years), symptoms included infection‐provoked autistic/language regression (n = 6), cognitive decline (n = 3), gait deterioration (n = 3), or abrupt‐onset anxiety, obsessive‐compulsive disorder, and/or tics (n = 5). Three children had ongoing infection‐provoked deteriorations. Six children benefited from intravenous immunoglobulin (n = 3) or antibiotics (n = 4). Ribonucleic acid expression of the eight chromatin genes was similar in neuronal, glial, and peripheral leukocytes, unlike non‐chromatin neurodevelopmental genes, which have predominantly neuronal expression. These cases demonstrate the role of chromatin dysregulation in autistic regression and abrupt‐onset neuropsychiatric syndromes, potentially related to brain and immune gene dysregulation.